Clinical Trial Update: Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome [NA]

View source ↗

Summary

A completed clinical trial evaluating vaginal micronized progesterone for withdrawal bleeding in women with PCOS found that circulating androgen levels were not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anovulation
• Hyperandrogenism
• Polycystic Ovary Syndrome

Drugs mentioned

• Vaginal micronized progesterone (progesterone (vaginally administered))

Snippet

Sponsor: Fundacion Dexeus | Conditions: Anovulation, Polycystic Ovary Syndrome | NA | Status: COMPLETED